Global Blood Therapeutics, Inc.

DB:G5B 주식 보고서

시가총액: €4.7b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Global Blood Therapeutics 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?


최근 내부자 거래

내부자 거래량

내부자 구매: G5B insiders have only sold shares in the past 3 months.


소유권 분석

G5B 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
개인 내부자1,520,4502.07%
VC/PE 기업3,646,6904.97%
헤지 펀드3,732,5025.09%
교육기관64,468,21987.9%

주식의 희석: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.1%.


최대 주주

상위 25 주주가 회사의 82.35%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
8.92%
The Vanguard Group, Inc.
6,019,431€418.2m-0.08%0.01%
7.07%
BlackRock, Inc.
4,772,391€331.5m-9.69%0.01%
6.64%
Janus Henderson Group plc
4,478,248€311.1m-20.1%0.17%
6.56%
State Street Global Advisors, Inc.
4,423,544€307.3m28%0.02%
5.53%
Baker Bros. Advisors LP
3,732,502€259.3m12.6%1.49%
5.4%
Deep Track Capital, LP
3,646,690€253.3m58.2%11.97%
4.6%
T. Rowe Price Group, Inc.
3,106,801€215.8m-2.34%0.03%
4.57%
FMR LLC
3,081,637€214.1m-24.7%0.02%
4.47%
Perceptive Advisors LLC
3,015,054€209.5m-22.5%6.19%
3.26%
Kynam Capital Management, LP
2,200,000€152.8m64.3%28.3%
3.03%
OrbiMed Advisors LLC
2,044,000€142.0m29.7%2.37%
2.35%
Point72 Asset Management, L.P.
1,586,974€110.2m70.4%0.3%
2.23%
Yiheng Capital Management, L.P.
1,501,382€104.3m0%6.81%
2.14%
Paradigm Biocapital Advisors LP
1,445,566€100.4m49.5%18.65%
2%
Citadel Advisors LLC
1,351,554€93.9m-31.3%0.14%
1.62%
Polar Capital Holdings plc
1,095,810€76.1m0%0.4%
1.61%
Geode Capital Management, LLC
1,083,836€75.3m-0.26%0.01%
1.41%
Fairmount Funds Management LLC
953,396€66.2m-19.4%11.62%
1.41%
BNPP Asset Management Holding
951,111€66.1m47.9%0.14%
1.4%
Woodline Partners LP
947,614€65.8m0%1.07%
1.37%
Ted Love
922,618€64.1m-16.6%데이터 없음
1.19%
Driehaus Capital Management LLC
805,861€56.0m0%0.61%
1.19%
The Roosevelt Investment Group, LLC
802,390€55.7m34.4%3.9%
1.19%
Casdin Capital, LLC
800,000€55.6m-39.6%3.85%
1.18%
Morgan Stanley, Investment Banking and Brokerage Investments
797,986€55.4m40.7%0.01%